EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to the annual defense reauthorization (HR 4438)

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC); Internal Revenue Service (IRS); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO)

Bills named: H.R. 4438 (113th)

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform law.

Contacted: Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Office of Personnel Management (OPM); SENATE; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Executive Office of the President (EOP); Government Accountability Office (GAO); White House Office; Food & Drug Administration (FDA)

Health Issues HCR

Regulatory policies related to the health reform law: structure, drug benefits, disclosure. Regulatory implementation of HITECH/Accounting of Disclosures Issues regarding making prescription drugs more affordable (generic user fees, pedigree, pathway for biosimilars, REMs). Restrictions on specialty tiering. HR 460.

Contacted: White House Office; Federal Trade Commission (FTC); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); SENATE; Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Internal Revenue Service (IRS); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Food & Drug Administration (FDA)

Bills named: H.R. 460 (113th)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General legislative and regulatory issues such as direct negotiation (budget proposals). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors prompt pay discounts from the definition of average sales price. Medicare audit and preferred network restrictions. S. 867, HR 4437, HR 4577. General issues and legislation (HR 3392) regarding combatting Rx abuse in Medicare and Medicaid (pharmacy lock in, etc.).

Contacted: Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); Labor, Dept of (DOL); Government Accountability Office (GAO); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Medicare Payment Advisory Commission (MedPAC); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Executive Office of the President (EOP)

Bills named: H.R. 4437 (113th), H.R. 3392 (113th), S. 867 (113th), H.R. 4577 (113th)

Pharmacy PHA

Policies related to FEHBP's pharmacy benefit (HR 1367). Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR. Specialty pharmacy tiering restrictions (HR 460). Regulatory implementation of a pathway for the approal of biosimilars. REMs. 340b program reform. Policies placing restrictions on pharmcy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse (HR 3392) including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding (PDSQ Act). S. 867, HR 4437, HR 4577.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Internal Revenue Service (IRS); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); Federal Trade Commission (FTC); Food & Drug Administration (FDA)

Bills named: S. 867 (113th), H.R. 4577 (113th), H.R. 3392 (113th), H.R. 1367 (113th), H.R. 4437 (113th), H.R. 460 (113th)

Postal POS

Postal reform proposals and their impact on 6 day mail delivery.

Contacted: Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); White House Office; Federal Trade Commission (FTC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Food & Drug Administration (FDA); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Internal Revenue Service (IRS)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for the purposes of negotiating with payers (HR 1188)

Contacted: Government Accountability Office (GAO); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); White House Office; Internal Revenue Service (IRS); SENATE; Executive Office of the President (EOP); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC)

Bills named: H.R. 1188 (113th)